Immunogenicity of Subcutaneously Administered Therapeutic Proteins—a Mechanistic Perspective

Journal Title: The AAPS Journal - Year 2013, Vol 15, Issue 4

Abstract

The administration of therapeutic proteins via the subcutaneous route (sc) is desired for compliance and convenience, but could be challenging due to perceived immunogenic potential or unwanted immune responses. There are clinical and preclinical data supporting as well as refuting the generalized notion that sc is more immunogenic. We provide a mechanistic perspective of immunogenicity of therapeutic proteins administered via the sc route and discuss strategies and opportunities for novel therapeutic approaches to mitigate immunogenicity.

Authors and Affiliations

Anas M. Fathallah, Richard B. Bankert, Sathy V. Balu-Iyer

Keywords

Related Articles

Relationship between steady-state pharmacokinetics and hemodynamic effects of inhaled isobutyl nitrite in conscious rats

Our objective was to examine the pharmacokinetic/hemodynamic properties of inhaled isobutyl nitrite (ISBN) in rats. ISBN is one of the volatile organic nitrites that has been used primarily as a drug of abuse. Recent stu...

Selected physical and chemical properties of commercial Hypericum perforatum extracts relevant for formulated product quality and performance

Objective. The complex composition-activity relationship of botanicals such as St John's Wort (SJW) presents a major challenge to product development, manufacture, and establishment of appropriate quality and performance...

Critical Factors Influencing the In Vivo Performance of Long-acting Lipophilic Solutions—Impact on In Vitro Release Method Design

Parenteral long-acting lipophilic solutions have been used for decades and might in the future be used in the design of depots with tailored delivery characteristics. The present review highlights major factors influenci...

Prodrug Approaches for CNS Delivery

Central nervous system (CNS) drug delivery remains a major challenge, despite extensive efforts that have been made to develop novel strategies to overcome obstacles. Prodrugs are bioreversible derivatives of drug molecu...

Antidrug Antibody Assay Validation: Industry Survey Results

Immunogenicity of biopharmaceutical products has attracted considerable attention from the industrial, academia, and regulatory organizations. Many methods exist to detect and characterize level of antidrug antibody resp...

Download PDF file
  • EP ID EP681148
  • DOI  10.1208/s12248-013-9510-6
  • Views 48
  • Downloads 0

How To Cite

Anas M. Fathallah, Richard B. Bankert, Sathy V. Balu-Iyer (2013). Immunogenicity of Subcutaneously Administered Therapeutic Proteins—a Mechanistic Perspective. The AAPS Journal, 15(4), -. https://europub.co.uk/articles/-A-681148